These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7828457)

  • 61. Urinary proteins and enzymes as early indicators of renal dysfunction in chronic exposure to cadmium.
    Jung K; Pergande M; Graubaum HJ; Fels LM; Endl U; Stolte H
    Clin Chem; 1993 May; 39(5):757-65. PubMed ID: 7683580
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.
    De Cock RF; Allegaert K; Schreuder MF; Sherwin CM; de Hoog M; van den Anker JN; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Feb; 51(2):105-17. PubMed ID: 22229883
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of aminoglycoside on ascending auditory pathway evaluated by evoked potentials].
    Lin CH; Chen TJ; Chen SS
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Sep; 10(9):497-507. PubMed ID: 7983694
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
    Marik PE; Havlik I; Monteagudo FS; Lipman J
    J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Once-daily gentamicin dosing in newborn infants.
    Lundergan FS; Glasscock GF; Kim EH; Cohen RS
    Pediatrics; 1999 Jun; 103(6 Pt 1):1228-34. PubMed ID: 10353934
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aminoglycoside ototoxicity.
    Matz GJ
    Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Aminoglycoside trough levels in neonates].
    Pejović B; Ranković-Janevski M; Bozinović-Prekajski N
    Srp Arh Celok Lek; 2010; 138(1-2):50-5. PubMed ID: 20425909
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment.
    Tirelli AS; Colombo N; Cavanna G; Mangioni C; Assael BM
    Eur J Clin Pharmacol; 1985; 29(3):313-8. PubMed ID: 3908127
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ototoxicity of amikacin.
    Black RE; Lau WK; Weinstein RJ; Young LS; Hewitt WL
    Antimicrob Agents Chemother; 1976 Jun; 9(6):956-61. PubMed ID: 938024
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.
    Unal S; Kotan C; Delibas A; Oztas Y
    Pediatr Hematol Oncol; 2015 May; 32(4):250-7. PubMed ID: 23987825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An evaluation of amikacin nephrotoxicity in the hematology/oncology population.
    Kiel PJ; Lo M; Stockwell D; Patel GP
    Am J Ther; 2008; 15(2):131-6. PubMed ID: 18356633
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary excretion of N-acetyl-glucosaminidase and beta-2-microglobulin as early markers of gentamicin nephrotoxicity in neonates.
    Gouyon JB; Aujard Y; Abisror A; Laudignon N; d'Athis P; Jacqz E; Biou D; Demelier JF; Mathieu H
    Dev Pharmacol Ther; 1987; 10(2):145-52. PubMed ID: 3301233
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.
    Smits A; De Cock RF; Allegaert K; Vanhaesebrouck S; Danhof M; Knibbe CA
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6344-51. PubMed ID: 26248375
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation.
    Viscoli C; Dudley M; Ferrea G; Boni L; Castagnola E; Barretta MA; Lanino E; Loy A; Moroni C; Somenzi M
    J Antimicrob Chemother; 1991 May; 27 Suppl C():113-20. PubMed ID: 1856140
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of renal enzymuria and cellular excretion as an marker of acute nephrotoxicity due to an overdose of paracetamol in Wistar rats.
    da Silva Melo DA; Saciura VC; Poloni JA; Oliveira CS; Filho JC; Padilha RZ; Reichel CL; Neto EJ; Oliveira RM; D'avila LC; Kessler A; de Oliveira JR
    Clin Chim Acta; 2006 Nov; 373(1-2):88-91. PubMed ID: 16806140
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.
    Labaune JM; Bleyzac N; Maire P; Jelliffe RW; Boutroy MJ; Aulagner G; Putet G
    Biol Neonate; 2001 Aug; 80(2):142-7. PubMed ID: 11509814
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Assessment of the nephrotoxicity of amikacin in patients with cystic fibrosis].
    Hügli R; Artho G; Wiesmann UN; Peheim E; Schaad UB; Bianchetti MG
    Schweiz Med Wochenschr; 1992 Jun; 122(24):930-5. PubMed ID: 1377401
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates.
    Kiatchoosakun P; Kosalaraksa P; Jirapradittha J; Taksaphan S; Tassniyom S
    J Med Assoc Thai; 2005 Jul; 88(7):934-8. PubMed ID: 16241022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.